Medical Oncology

Gestational Trophoblastic Disease

Questions discussed in this category

What are your top takeaways from SGO 2023?

7 Answers available

What is your approach to first line systemic treatment for low risk gestational trophoblastic neoplasia?

Is there an optimal chemotherapy regimen that optimizes cure rates while minimizing side effects?

2 Answers available

How does your approach to low-risk gestational trophoblastic neoplasia differ for patients whose hCG levels plateau following initial single agent systemic therapy vs those who have a good initial response and then plateau?

1 Answer available

In a patient with high-risk gestational trophoblastic neoplasia, how would you approach treatment of recurrence at 6 months post EMA-CO?

Tolerated first line, however now with rising Beta-HCG, new mass in uterus, and pulmonary metastases.

1 Answer available

Papers discussed in this category

Cochrane Database Syst Rev, 2016 Jun 09

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

BMC Cancer, 2021 Oct 18

Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies.

N Engl J Med, 2023 Mar 27

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

N Engl J Med, 2023 Mar 27

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Related Topics in Medical Oncology